Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic event, enabling teams to act while treatment decisions are still pending; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers scientific and advisory services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Frequently asked questions
What sector does Diaceutics PLC (DIUXF) operate in?
Diaceutics PLC belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Diaceutics PLC (DIUXF) current stock price?
As of the latest data, Diaceutics PLC stock price is $2.31, with a previous close of $2.31.
What is Diaceutics PLC (DIUXF) current market capitalization?
Diaceutics PLC market cap is approximately 195.95 million.
What is Diaceutics PLC (DIUXF) EBITDA?
Diaceutics PLC EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -725.87 thousand.
Does Diaceutics PLC (DIUXF) pay dividends?
No. Diaceutics PLC does not pay a dividend.
What is Diaceutics PLC (DIUXF) beta (volatility) score?
Diaceutics PLC has a beta of 0.769, indicating lower volatility than the overall market.
